Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Accrued Expenses and Long-term Liabilities (Tables)

Note 7 - Accrued Expenses and Long-term Liabilities (Tables)

9 Months Ended

Sep. 30, 2016

Notes Tables

Schedule of Accrued Liabilities [Table Text Block]

		September 30, 2016				December 31, 2015
Accrued royalties		$	504			$	111
Self insurance and benefit accruals			272				366
Indemnification liability			875				875
Contingent consideration			209				659
Rent payable			78				127
DOJ settlement			665				250
Accrued professional fees			1,320				775
Taxes payable			691				591
Unclaimed property			544				546
Directors fees and insurance			208				107
All others			1,539				1,554
		$	6,905			$	5,961

Schedule of Other Assets and Other Liabilities [Table Text Block]

		September 30, 2016				December 31, 2015
Rent payable		$	-			$	52
Uncertain tax positions			3,556				3,425
DOJ settlement (indemnified by RedPath)			1,000				2,500
Other			59				201
		$	4,615			$	6,178